- Report
- August 2022
- 54 Pages
Global
From €2237EUR$2,450USD£1,899GBP
- Report
- February 2022
- 77 Pages
Global
From €2237EUR$2,450USD£1,899GBP
- Report
- December 2021
- 55 Pages
Global
- Report
- December 2021
- 58 Pages
Global
From €4519EUR$4,950USD£3,836GBP
- Report
- November 2021
- 55 Pages
Europe
From €2237EUR$2,450USD£1,899GBP
- Report
- November 2021
- 40 Pages
Global
From €4519EUR$4,950USD£3,836GBP
- Report
- December 2020
- 34 Pages
Global
From €4519EUR$4,950USD£3,836GBP
- Report
- April 2019
- 73 Pages
Global
From €4519EUR$4,950USD£3,836GBP
- Report
- August 2021
- 77 Pages
Global
From €4519EUR$4,950USD£3,836GBP
- Report
- April 2024
- 279 Pages
Global
From €3196EUR$3,500USD£2,712GBP
€4565EUR$5,000USD£3,875GBP
- Report
- April 2023
- 275 Pages
Global
From €3196EUR$3,500USD£2,712GBP
€4565EUR$5,000USD£3,875GBP
- Report
- September 2022
- 175 Pages
Global
From €4565EUR$5,000USD£3,875GBP
- Report
- July 2022
- 416 Pages
Global
From €3196EUR$3,500USD£2,712GBP
€4565EUR$5,000USD£3,875GBP
- Report
- July 2022
- 276 Pages
Global
From €3196EUR$3,500USD£2,712GBP
€4565EUR$5,000USD£3,875GBP
- Report
- July 2023
- 150 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- January 2023
- 150 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- January 2021
- 160 Pages
Global
From €5433EUR$5,950USD£4,611GBP
- Report
- November 2023
- 170 Pages
Global
From €2054EUR$2,250USD£1,744GBP
- Report
- July 2023
- 280 Pages
Global
From €2237EUR$2,450USD£1,899GBP
- Report
- November 2022
- 340 Pages
Global
From €2191EUR$2,400USD£1,860GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more